- Home
- ARBB vs XTLB Comparison
ARBB vs XTLB Comparison
Compare ARBB & XTLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- XTLB
- Stock Information
- Founded
- ARBB 1997
- XTLB 1993
- Country
- ARBB Singapore
- XTLB Israel
- Employees
- ARBB N/A
- XTLB N/A
- Industry
- ARBB EDP Services
- XTLB Biotechnology: Pharmaceutical Preparations
- Sector
- ARBB Technology
- XTLB Health Care
- Exchange
- ARBB Nasdaq
- XTLB Nasdaq
- Market Cap
- ARBB 14.9M
- XTLB 16.3M
- IPO Year
- ARBB 2023
- XTLB 2005
- Fundamental
- Price
- ARBB $0.44
- XTLB $1.67
- Analyst Decision
- ARBB
- XTLB
- Analyst Count
- ARBB 0
- XTLB 0
- Target Price
- ARBB N/A
- XTLB N/A
- AVG Volume (30 Days)
- ARBB 107.8K
- XTLB 8.8K
- Earning Date
- ARBB 11-22-2024
- XTLB 02-21-2025
- Dividend Yield
- ARBB N/A
- XTLB N/A
- EPS Growth
- ARBB N/A
- XTLB N/A
- EPS
- ARBB N/A
- XTLB N/A
- Revenue
- ARBB $12,334,474.00
- XTLB $46,000.00
- Revenue This Year
- ARBB N/A
- XTLB N/A
- Revenue Next Year
- ARBB N/A
- XTLB N/A
- P/E Ratio
- ARBB N/A
- XTLB N/A
- Revenue Growth
- ARBB N/A
- XTLB N/A
- 52 Week Low
- ARBB $0.22
- XTLB $0.77
- 52 Week High
- ARBB $4.55
- XTLB $4.99
- Technical
- Relative Strength Index (RSI)
- ARBB 42.37
- XTLB 46.19
- Support Level
- ARBB $0.43
- XTLB $1.56
- Resistance Level
- ARBB $0.54
- XTLB $1.70
- Average True Range (ATR)
- ARBB 0.04
- XTLB 0.13
- MACD
- ARBB -0.01
- XTLB -0.02
- Stochastic Oscillator
- ARBB 33.17
- XTLB 42.55
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.
About XTLB XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.